We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current 0KWF market cap is 735.24M. The company's latest EPS is BGN 0.5516 and P/E is 7.72.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| BGN (BGN) | BGN (BGN) | BGN (BGN) | BGN (BGN) | BGN (BGN) | |
| Total Revenue | 1.29B | 1.45B | 1.61B | 1.67B | 1.89B |
| Operating Income | 43.27M | 56.55M | 114.58M | 115.39M | 129.72M |
| Net Income | 89.62M | 29.81M | 89.5M | 71.12M | 95.21M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| BGN (BGN) | BGN (BGN) | BGN (BGN) | BGN (BGN) | BGN (BGN) | |
| Total Assets | 1.18B | 1.24B | 1.2B | 1.25B | 1.51B |
| Total Liabilities | 596.59M | 675.52M | 546.11M | 537.34M | 757.08M |
| Total Equity | 581.07M | 566.6M | 658.87M | 716.63M | 752.81M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| BGN (BGN) | BGN (BGN) | BGN (BGN) | BGN (BGN) | BGN (BGN) | |
| Operating | -127.72M | -179.41M | -75.96M | 110.08M | 45.03M |
| Investing | -104.89M | 1.5M | -68.07M | -63.61M | -62.85M |
| Financing | 235.87M | 175.69M | 156.61M | -64.34M | 126.85M |
| Market Cap | 735.24M |
| Price to Earnings Ratio | 7.72 |
| Price to Sales Ratio | 0.39 |
| Price to Cash Ratio | 5.7 |
| Price to Book Ratio | 0.98 |
| Dividend Yield | - |
| Shares Outstanding | 172.59M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Sopharma Ad |
| Address |
16, iliensko shousse street sofia 1220 |
| Website | https://www.sopharmagroup.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
